Current Edition

Psychedelics Make a Comeback to Treat
Volume 12 Issue 6

Psychedelics Make a Comeback to Treat Mental Health Conditions

The FDA has approved only two products to treat TRD, and several companies are evaluating products with psychedelic properties as a new approach to previously …

Continue Reading →
Combating Covid-19 Cold Chain Challenges
Volume 12 Issue 6

Combating Covid-19 Cold Chain Challenges

As the world continues to react to the impact of the global pandemic, by far the most significant challenges currently for pharmaceutical cold chain logistics …

Continue Reading →
Practical Implications of Undertaking Clinical Trials
Volume 12 Issue 6

Practical Implications of Undertaking Clinical Trials during the COVID-19 Pandemic

Faced with the coronavirus pandemic, restrictions and ever-fluctuating situations have necessitated changes to ongoing andfuture clinical trials. Nariné Baririan at SGS explains why practical and …

Continue Reading →
New FDA Guidance on Endpoints for
Volume 12 Issue 6

New FDA Guidance on Endpoints for Demonstrating Effectiveness of Drugs for Treatment of Opioid Use Disorder

Use and abuse of opioid products has increased alarmingly over the last 20 years, along with deaths due to overdose. Now commonly referred to as …

Continue Reading →
The Importance of Global Collaboration
Volume 12 Issue 6

The Importance of Global Collaboration for Successful Paediatric Development

The paediatric population which needs treatment is small compared to the adult population, hence the necessity for global drug development. Paediatric legislation is not global, …

Continue Reading →
Regenerative Medicine_Hype and Hope or Safety and Efficacy.
Volume 12 Issue 6

Regenerative Medicine: Hype and Hope or Safety and Efficacy?

Regenerative medicine, and the underlying stem cell technology on which it is based, offers considerable hope to patients suffering from trauma and chronic disease. Despite …

Continue Reading →
The Role of eConsent in Remote Trials
Volume 12 Issue 6

The Role of eConsent in Remote Trials

Today’s clinical trials demand flexible approaches and solutions. The drive to make trial participation more convenient and more inclusive for patients living greater distances from …

Continue Reading →
Clinical Development in Inflammatory
Volume 12 Issue 6

Clinical Development in Inflammatory Diseases: Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterised by an inflammatory polyarthritis that preferentiallyaffects the small joints. RA is a “multicausal” disease. Dr. Peter …

Continue Reading →
For Paediatric Participants, Patient-centric
Volume 12 Issue 6

For Paediatric Participants, Patient-centric Trials Must Be Family-centric

Clinical research in paediatric patients has long been the subject of ethical debate, focusing on topics as varied as a minor’s ability to make an …

Continue Reading →
Precision Medicine_Targeted Therapy
Volume 12 Issue 6

Precision Medicine: Targeted Therapy in Paediatric Oncology Patients

Targeted therapy depends on targeting unique receptors or proteins in the malignant cells, thus leading to fewer chemotherapy-induced adverse effects. Subhajit Hazra and Sara Ahmed …

Continue Reading →